Ferraro, Pietro Manuel
 Distribuzione geografica
Continente #
NA - Nord America 5.430
AS - Asia 4.382
EU - Europa 4.226
SA - Sud America 1.138
AF - Africa 177
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 16
Totale 15.394
Nazione #
US - Stati Uniti d'America 5.294
SG - Singapore 1.928
CN - Cina 1.296
BR - Brasile 967
SE - Svezia 812
DE - Germania 688
IT - Italia 538
PL - Polonia 501
FR - Francia 456
IE - Irlanda 279
UA - Ucraina 258
VN - Vietnam 232
ID - Indonesia 189
IN - India 182
FI - Finlandia 153
RU - Federazione Russa 151
GB - Regno Unito 140
TR - Turchia 122
BD - Bangladesh 69
CI - Costa d'Avorio 69
IQ - Iraq 61
CA - Canada 56
AR - Argentina 53
BE - Belgio 53
HK - Hong Kong 50
MX - Messico 44
JP - Giappone 42
NL - Olanda 35
AT - Austria 32
ZA - Sudafrica 32
EC - Ecuador 30
IR - Iran 24
MA - Marocco 23
CO - Colombia 22
SA - Arabia Saudita 21
AU - Australia 20
PK - Pakistan 20
CZ - Repubblica Ceca 19
PY - Paraguay 19
ES - Italia 18
CH - Svizzera 17
KR - Corea 17
VE - Venezuela 17
AZ - Azerbaigian 12
JO - Giordania 11
PE - Perù 11
RO - Romania 11
AL - Albania 10
LT - Lituania 10
BG - Bulgaria 9
CL - Cile 9
EG - Egitto 9
EU - Europa 9
KE - Kenya 9
TW - Taiwan 9
UZ - Uzbekistan 9
IL - Israele 8
PH - Filippine 8
TN - Tunisia 8
A2 - ???statistics.table.value.countryCode.A2??? 7
AE - Emirati Arabi Uniti 7
DZ - Algeria 7
JM - Giamaica 7
PT - Portogallo 7
TH - Thailandia 7
CR - Costa Rica 6
GR - Grecia 6
KH - Cambogia 6
KZ - Kazakistan 6
LB - Libano 6
NP - Nepal 6
DO - Repubblica Dominicana 5
MY - Malesia 5
NG - Nigeria 5
NZ - Nuova Zelanda 5
UY - Uruguay 5
BO - Bolivia 4
GE - Georgia 4
HN - Honduras 4
HU - Ungheria 4
AF - Afghanistan, Repubblica islamica di 3
BH - Bahrain 3
KG - Kirghizistan 3
MD - Moldavia 3
OM - Oman 3
PA - Panama 3
SN - Senegal 3
AM - Armenia 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BY - Bielorussia 2
CG - Congo 2
CY - Cipro 2
HR - Croazia 2
NO - Norvegia 2
RS - Serbia 2
SY - Repubblica araba siriana 2
BF - Burkina Faso 1
BS - Bahamas 1
Totale 15.365
Città #
Chandler 875
Singapore 799
Ashburn 487
Beijing 336
Kraków 327
Dublin 272
Jacksonville 217
San Mateo 186
Ann Arbor 185
Wilmington 181
New York 170
Warsaw 170
Jakarta 163
Nanjing 157
Hangzhou 152
Los Angeles 152
Boston 120
Dallas 109
Rome 93
Woodbridge 89
São Paulo 87
Dearborn 85
Fairfield 83
Ho Chi Minh City 83
Milan 80
Princeton 77
Moscow 75
Hefei 74
Houston 70
Lawrence 70
Abidjan 69
Izmir 69
Frankfurt am Main 64
The Dalles 64
Hanoi 57
Redwood City 57
Seattle 53
Brussels 51
Hong Kong 49
Munich 49
Helsinki 48
Bremen 46
Nanchang 45
Boardman 43
Marseille 42
Buffalo 39
Mountain View 39
Cattolica 38
Shenyang 36
Regensburg 35
Santa Clara 35
Tokyo 35
Chicago 34
Falls Church 33
Norwalk 29
Redmond 29
Augusta 27
Hebei 26
Andover 25
Toronto 24
Dhaka 23
Nuremberg 22
Busto Arsizio 21
Kunming 21
Tianjin 21
London 20
Rio de Janeiro 20
Shanghai 20
Belo Horizonte 19
Brooklyn 19
Jiaxing 19
Kish 19
San Francisco 19
Vienna 18
Brasília 17
Detroit 17
Lappeenranta 17
Düsseldorf 16
Erbil 16
Orem 16
Brno 15
Cambridge 15
Changsha 15
Denver 15
Johannesburg 15
Phoenix 15
Seoul 15
Zhengzhou 15
Amsterdam 14
Chennai 14
Guangzhou 14
Guayaquil 14
Montreal 14
Poplar 14
Pune 14
Campinas 13
Nürnberg 13
Stockholm 13
Turku 13
Baghdad 12
Totale 7.976
Nome #
New semiquantitative ultrasonographic score for peripheral arterial disease assessment and its association with cardiovascular risk factors 431
LOW LEVEL EXPOSURE TO CADMIUM INCREASES THE RISK OF CHRONIC KIDNEY DISEASE: ANALYSIS OF THE NHANES 1999-2006. 277
Small intestinal bacterial overgrowth and intestinal permeability. 193
Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study 186
Characterization of the Protein Components of Matrix Stones Sheds Light on S100-A8 and S100-A9 Relevance in the Inflammatory Pathogenesis of These Rare Renal Calculi 184
A Specific Urinary Amino Acid Profile Characterizes People with Kidney Stones 173
When to suspect a genetic disorder in a patient with renal stones, and why 167
Mediterranean diet adherence and risk of incident kidney stones 160
Ayurvedic medicine and NADPH oxidase: a possible approach to the prevention of ESRD in hyperoxaluria. 159
FT-IR Analysis of Urinary Stones: A Helpful Tool for Clinician Comparison with the Chemical Spot Test, 157
Regression of endothelial dysfunction in patients with endometriosis after surgical treatment: a 2-year follow-up study 157
Pancreaticoduodenectomy model demonstrates a fundamental role of dysfunctional β cells in predicting diabetes 155
Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group 150
Effect of Dapagliflozin on Myocardial Insulin Sensitivity and Perfusion: Rationale and Design of The DAPAHEART Trial 150
Endothelial dysfunction but not increased carotid intima-media thickness in young European women with endometriosis 147
Caffeine intake and the risk of kidney stones 142
Risk of recurrence of idiopathic calcium kidney stones: analysis of data from the literature 141
Inflammatory Cytokines Associated With Failure of Lower-Extremity Endovascular Revascularization (LER): A Prospective Study of a Population With Diabetes. 139
Increased B-cell workload modulates proinsulin-to-insulin ratio in humans 138
Effects of prednisone on biomarkers of tubular damage induced by radiocontrast in interventional cardiology 137
Dietary Protein and Potassium, Diet-Dependent Net Acid Load, and Risk of Incident Kidney Stones 137
A paraneoplastic retroperitoneal fibrosis resistant to corticosteroids treated with tamoxifen. 132
Role of Fourier transform infrared (FT-IR) spectroscopy in the evaluation of urinary stone disease 130
Neutrophil gelatinase-associated lipocalin (NGAL) value changes before and after shock wave lithotripsy 129
Cadmium Exposure and Kidney Stone Formation in the General Population An Analysis of the National Health and Nutrition Examination Survey III Data 128
EFFECT OF WATER COMPOSITION AND TIMING OF INGESTION ON URINARY LITHOGENIC PROFILE IN HEALTHY VOLUNTEERS - A RANDOMIZED CROSSOVER TRIAL 127
Safety of antithrombotic therapy in subjects with hereditary hemorrhagic telangiectasia: prospective data from a multidisciplinary working group 127
Stone composition and vascular calcifications in patients with nephrolithiasis 126
A rapid screening of a recurrent CYP24A1 pathogenic variant opens the way to molecular testing for Idiopathic Infantile Hypercalcemia (IIH) 125
A STARD-compliant prediction model for diagnosing thrombotic microangiopathies 124
Randall's plaques, plugs and the clinical workup of the renal stone patient 123
Effect of water composition and timing of ingestion on urinary lithogenic profile in healthy volunteers: a randomized crossover trial 123
Hyperchloremia and acute kidney injury: a retrospective observational cohort study on a general mixed medical-surgical not ICU-hospitalized population 121
A novel CYP24A1 genotype associated to a clinical picture of hypercalcemia, nephrolithiasis and low bone mass 120
Total, dietary, and supplemental Vitamin C intake and risk of incident kidney stones 119
The Risk of Chronic Kidney Disease Associated With Urolithiasis and its Urological Treatments: a Review 119
Antibiotic Use and Risk of Incident Kidney Stones in Female Nurses 117
Age- and sex-tailored serum phosphate thresholds do not improve cardiovascular risk estimation in CKD. 115
Total, Dietary, and Supplemental Vitamin C Intake and Risk of Incident Kidney Stones 113
The relationship between calcium kidney stones, arterial stiffness and bone density: unraveling the stone-bone-vessel liaison 112
[Hyponatremia: practical approach to diagnosis and treatment] 111
Sodium Fluctuations and Mortality in a General Hospitalized Population 111
Dietetic and lifestyle recommendations for stone formers 111
A comparison between 24h urine collection and overnight spot urines in evaluating the risk of stone disease 110
[Salvage of vascular access: a case study from the Columbus nephrology division, Rome, Italy] 109
Contrast-enhanced ultrasonography in chronic glomerulonephritides: correlation with histological parameters of disease activity 109
Changes in renal papillary density after hydration therapy in calcium stone formers 109
Living Kidney Donation in a Type 1 Dent's Disease Patient from His Mother 109
[The Italian Registry for Therapeutic Apheresis: fifteen years of activity] 107
Living kidney donation from people at risk of nephrolithiasis, with a focus on the genetic forms 107
Chronic pain in medullary sponge kidney: a rare and never described clinical presentation 107
TEMPORAL TREND OF CADMIUM EXPOSURE IN THE U.S. POPULATION SUGGESTS GENDER SPECIFICITIES 106
Association between peripheral arterial disease and cardiovascular risk factors: role of ultrasonography versus ankle-brachial index 105
Reduced incretin effect precedes diabetes development following duodenopancreatectomy in individuals without diabetes 103
Dapagliflozin improves myocardial flow reserve in patients with type 2 diabetes: the DAPAHEART Trial: a preliminary report 102
Calcium nephrolithiasis, metabolic syndrome and the cardiovascular risk 102
PREVALENCE OF CKD IN NORTHEASTERN ITALY: RESULTS OF THE INCIPE STUDY AND COMPARISON WITH NHANES. 102
Soda and other beverages and the risk of kidney stones 102
Metabolic syndrome and uric acid nephrolithiasis: insulin resistance in focus 102
A London experience 1995-2012: demographic, dietary and biochemical characteristics of a large adult cohort of patients with renal stone disease 101
Bile modulates secretion of incretins and insulin: a study on human extrahepatic cholestasis 101
Prevalence of renal stones in an Italian urban population: a general practice-based study 100
Combined treatment with renin-angiotensin system blockers and polyunsaturated fatty acids in proteinuric IgA nephropathy: A randomized controlled trial 100
A novel CYP24A1 genotype associated to a clinical picture of hypercalcemia, nephrolithiasis and low bone mass (vol 45, pg 291, 2016) 100
Risk of kidney stones: Influence of dietary factors, dietary patterns, and vegetarian–vegan diets 100
Deterioration in Clinical Status Is Not Enough to Suspend Eculizumab: A Genetic Complement-Mediated Atypical Hemolytic Uremic Syndrome Case Report 99
Assessing the Best Prognostic Score for Transcatheter Aortic Valve Implantation (from the RISPEVA Registry) 99
Recurrent Kidney Stones in a patient with Malabsorption Syndrome 99
Intra-islet insulin synthesis defects are associated with endoplasmic reticulum stress and loss of beta cell identity in human diabetes 98
Results of a gene panel approach in a cohort of patients with incomplete distal renal tubular acidosis and nephrolithiasis 98
Neutrophil-to-lymphocyte ratio but not monocyte-to-HDL cholesterol ratio nor platelet-to-lymphocyte ratio correlates with early stages of lower extremity arterial disease: An ultrasonographic study 98
Erythrocyte membrane fluidity: A novel biomarker of residual cardiovascular risk in type 2 diabetes 97
Which diet for calcium stone patients: A real-world approach to preventive care 96
URINARY LITHOGENIC PROFILE IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE 93
Selective screening for distal renal tubular acidosis in recurrent kidney stone formers: Initial experience and comparison of the simultaneous furosemide and fludrocortisone test with the short ammonium chloride test 93
Vitamin D Intake and the Risk of Incident Kidney Stones 93
Seasonality of acute kidney injury in a tertiary hospital academic center: an observational cohort study 93
CKD prevalence varies across the European general population 92
Angiosarcoma of an Arteriovenous Fistula for Hemodialysis in a Kidney Transplant Recipient Affected by Lowe's Syndrome 91
Familial clustering of medullary sponge kidney is autosomal dominant with reduced penetrance and variable expressivity 90
Randall's plaques, plugs and the clinical workup of the renal stone patient 90
[Granulocyte-monocyte apheresis for the treatment of inflammatory bowel disease] 90
Improvement of Urinary Stones Analysis Combining Morphological Analysis and Infrared Spectroscopy 90
URINARY LITHOGENIC PROFILE IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE 89
Dapagliflozin treatment is associated with a reduction of epicardial adipose tissue thickness and epicardial glucose uptake in human type 2 diabetes 89
Tubular and genetic disorders associated with kidney stones 89
Recurrent kidney stones in a family with a mitochondrial disorder due to the m.3243A>G mutation 89
[Pulmonary-renal syndromes] 88
Regression of endothelial dysfunction in patients with endometriosis after surgical treatment: a 2-year follow-up study 87
Dietary oxalate intake and kidney outcomes 87
Distal Renal Tubular Acidosis: ERKNet/ESPN Clinical Practice Points 87
Short-Term Changes in Urinary Relative Supersaturation Predict Recurrence of Kidney Stones: A Tool to Guide Preventive Measures in Urolithiasis 86
Physical activity, energy intake, and the risk of incident kidney stones 85
Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement 84
A young girl with recurrent calculosis and hypercalcemia 84
Urinary lithogenic profile of patients with non-alcoholic fatty liver disease 83
A preliminary survey of practice patterns across several European kidney stone centers and a call for action in developing shared practice 83
Serum sodium variability and acute kidney injury: a retrospective observational cohort study on a hospitalized population 83
Predictive model for delayed graft function based on easily available pre-renal transplant variables 82
CKD Prevalence Varies across the European General Population 82
Totale 11.792
Categoria #
all - tutte 72.011
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.011


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021428 0 0 0 0 0 61 54 18 88 29 115 63
2021/20221.387 128 60 43 78 101 78 39 243 78 96 171 272
2022/20232.646 401 343 219 342 179 302 148 217 284 42 100 69
2023/20241.318 64 387 36 65 56 169 89 56 22 54 107 213
2024/20252.547 72 82 232 102 175 92 50 144 349 289 518 442
2025/20263.770 1.000 206 458 769 1.052 285 0 0 0 0 0 0
Totale 15.638